跳至主要内容
临床试验/NL-OMON56668
NL-OMON56668招募中不适用

Addition of GAAD score to imaging surveillance for early identification of liver cancer. - ADRENALI

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • - All patients with cirrhosis
  • - Non-cirrhotic chronic hepatitis B patients meeting any of the following
  • criteria: positive family history for hepatocellular carcinoma,
  • intermediate-high aMAP and/or (m)PAGE-B score (if non-Caucasian)
  • - Non-cirrhotic chronic hepatitis C patients (with or without SVR) with a
  • history of F3 fibrosis (based on histology or liver stiffness assessment)
  • - Non-cirrhotic NASH patients with a history of F3 fibrosis (based on histology
  • or liver stiffness assessment)

排除标准

  • - Diagnosis with any other cancer other than non-melanoma skin cancer
  • - History of hepatocellular carcinoma
  • - Women who are pregnant or lactating
  • - Patient with glomerular filtration rate <45 ml /min/1.73 m2
  • - Unwillingness or inability to undergo both CT and MRI imaging
  • - Life expectancy <2 years
  • - Use of vitamin K antagonists

研究者

相似试验